Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

NCT00549952 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2007-10-26

No results posted yet for this study

Summary

to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients

Conditions

  • Oral Mucositis

Interventions

OTHER

no intervention study

Sponsors & Collaborators

  • Otsuka Pharmaceutical Co., Ltd.

    collaborator INDUSTRY
  • Korea Otsuka Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Do-Youn Oh, PhD · Seoul National University Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Completion
2008-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00549952 on ClinicalTrials.gov